RU2006127945A -
METHOD FOR TREATING PATIENTS WITH IMPAIRED MEMORY FUNCTION
- Google Patents
METHOD FOR TREATING PATIENTS WITH IMPAIRED MEMORY FUNCTION
Download PDF
Info
Publication number
RU2006127945A
RU2006127945ARU2006127945/14ARU2006127945ARU2006127945ARU 2006127945 ARU2006127945 ARU 2006127945ARU 2006127945/14 ARU2006127945/14 ARU 2006127945/14ARU 2006127945 ARU2006127945 ARU 2006127945ARU 2006127945 ARU2006127945 ARU 2006127945A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сергей В чеславович Ширинкин (RU), Сергей Вячеславович ШиринкинfiledCriticalСергей В чеславович Ширинкин (RU)
Priority to RU2006127945/14ApriorityCriticalpatent/RU2335291C2/en
Publication of RU2006127945ApublicationCriticalpatent/RU2006127945A/en
Application grantedgrantedCritical
Publication of RU2335291C2publicationCriticalpatent/RU2335291C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Non-Alcoholic Beverages
(AREA)
Claims (1)
Способ лечения больных с нарушением функции памяти, включающий введение средства, обладающего ноотропной активностью, отличающийся тем, что в качестве средства, обладающего ноотропной активностью, используют водно-минеральный раствор природных фуллеренов концентрацией 0,25-0,5 мг/л, при этом раствор применяют в виде питья в течение 15 суток.A method of treating patients with impaired memory function, comprising administering an agent having nootropic activity, characterized in that an aqueous-mineral solution of natural fullerenes with a concentration of 0.25-0.5 mg / l is used as an agent having nootropic activity, the solution being used as a drink for 15 days.
RU2006127945/14A2006-07-282006-07-28Method of treatment of patients with memory dysfunction
RU2335291C2
(en)
COMPOSITION, KIT, AND METHODS TO REDUCE A SIDE TREATMENT EFFECT WITH A CALCINEURIN INHIBITOR, TO INCREASE A THERAPEUTIC EFFECT OF A CALCINEURIN INHIBITOR AND TO CHANGE THE CONCENTRATION OF TACROLIMUS OR ANALYLOGAL ANALOGUE